Sun Pharmaceutical Industries stock ended 2.15 per cent higher on Friday after zooming by almost 5 per cent in the morning trade on the back of an announcement that a court ruling has cleared the deck for the India's largest pharmaceutical company to launch its alopecia drug Leqselvi in the United States.
Nine Indian Americans are running for the US House of Representatives, which includes a re-election bid by six of them while three are making their maiden foray into Congressional politics.
Dr Reddy's Laboratories Ltd filed a lawsuit seeking declaratory judgement against Pfizer in United States District Court for the District of New Jersey regarding its Abbreviated New Drug Application for Sertraline HCl.
Sun Pharma's offer was tempting because Ranbaxy was too busy fighting fires in the US to concentrate on operations.
Slapped with Rs 242-crore fine by US authorities for rule violations at Toansa unit, say sources; 2nd such hefty rap in the recent past from US regulators for bending rules.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances